News

Healthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.

As managed care leaders, better care for patients can be achieved through increased medical data exchange through diverse and collaborative organization involvement.

Is interoperability in healthcare a dream, or will payers, providers, and technology vendors finally come together to make data more available to one another?

High customer satisfaction has been linked with stronger loyalty, sales, and profits. So why hasn’t the healthcare industry caught on?

Finding technology solutions to diagnose and manage chronic conditions is critical to the future of healthcare.

Is your organization on pace with the biggest healthcare technology trends? Here’s your chance to find out.

Five healthcare tech trends that will make chronic care management a part of patients’ daily lives.

Analysis from RAND helps frame the potential of biosimilars to reduce spending on biologics.

New data from CMS show that ACOs succeed at producing quality gains and cost savings, but at least one effort begs to differ.

How can we as an industry help address the growing need and demand for quality mental health services? One of the more promising solutions is the expanded use of certified physician assistants.

Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.

An Epstein Becker Green survey has surprising results about the expansion of telehealth services physicians and other behavioral health professionals can provide.

One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.

The success of any value-based care model depends on achieving a strong relationship with members. Here’s three ways how.

While many analyses of Section 1a of the executive order cite doom and gloom for health plans, four tenuous contingencies all must take place in order for this to occur.

FDA approved a new once-weekly, single-dose autoinjector device to improve glycemic control in adults with type 2 diabetes.

Payers’ biggest concerns for 2018, health insurance exchange participation plans, and how offerings could change.

A new study has unbelievable findings about treating Medicare patients with diabetes.

A Robert Wood Johnson Foundation expert analyzes the Altarum Institute’s study on healthcare growth findings.

As genomics continues to evolve, here are five things to know about genetic testing and counseling.

A survey explores how physicians perceive their role in the healthcare system, and the findings aren’t good.

A Physicians Foundation survey gives healthcare executives behind the scenes insight into the physician-patient relationship.

FDA incentives have hastened the development of “orphan drugs” for rare diseases, but some worry that regulators are not always demanding clear evidence for drug efficacy.

With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.

CAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.

A University of Massachusetts clinical consulting pharmacist shows how assessing budget implications can be accomplished.

CMS’ 5-Star Rating system requires proactive intervention to improve patient medication adherence, and leaves plans with little room to rest on their laurels.

Pre-drug-approval forecasting and budgeting is increasingly important for payers. Is a safe harbor for manufacturers necessary?